17 September 2018 / Paris, France
Hero Image
17 September 2018
Paris, France
Gene Therapy Partnering Day




Presentation of the DIM “Thérapie génique” initiative by Marina Cavazzana

Medicen Paris Region initiatives to support gene therapy development

9:10   Challenges in the field of Gene Therapy

  1. Technology tranfer:  Federico Mingozzi - Chief Scientific Officer, Spark Therapeutics 
  2.  "T-cell precursors to treat immune deficiencies" - Isabelle André-Schmutz - Group leader of Human Lymphohematopoiesis Lab, Imagine Institute
  3. Regulations- Nathalie Morgensztejn, Head of Department of Virology and Gene Therapy, ANSM
  4. “Reimbursement considerations for Gene Therapies”- Panos Kefalas - Head of Health Economics & Market Access, Cell and Gene Therapy Catapult

10:10    Pitch of research projects 

  1. "Dual AAV-mediated gene therapy cures deafness in a DFNB9 mouse model" - Said Safieddine - Researcher in Genetics and physiology of hearing lab, Pasteur Institute
  2. "Gene therapy approach to treat mitochondrial diseases caused by defects in mitochondrial gene expression" - Benedetta Ruzzenente -  Post-doctoral fellow, Genetics of mitochondrial diseases Lab, Imagine Institute
  3.  "Gene therapy for MSUD" - Manuel Schiff- Doctor, Reference centre for inherited metabolic diseases, Robert Debré Hospital and Imagine Institute
  4. "Development of an in vitro model for cerebral vasculopathy monitoring in gene therapy of sickle cell disease" - Kim-Anh Nguyen-Peyre - Postdoctoral fellow Transfusion and Pathologies of the Red Blood Cell, EFS
  5. "Gene therapy for sickle cell disease: new solutions explored" - Anne Galy - Director of integrated genetic approaches in therapeutic discovery for rare diseases, Généthon 
  6. "Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus" - Annarita Miccio - Group leader of Chromatin and gene regulation during development lab, Imagine Institute 
  7. "AAV vector platform for R&D purposes" - Marcelo Simon Sola - Engineer, AAV platform, Imagine Institute
  8. "Gene Therapy in haemophilia A : a hope for children too" - Annie Harroche- PH, Laboratory of biological hematology, Necker Enfants-Malades Hospital 


11:45   "Overview of gene therapy development by Pfizer" - Donna Armentano, Executive Director, Global Head GTx, External Science and Innovation at Pfizer, Inc.

12:00  Innovative technological solutions 

  1. Eukarÿs - Philippe Jais, CEO & CSO 
  2. Flash Therapeutics - Pascale Bouillé, President & founder 
  3. BrainVectis - Sandro Alves , Director of Preclinical Research 
  4. AmplyCell - Bastien Horrion, CSO 
  5. 20Med Therapeutics -  Lodder Michiel, CEO
  6. Amarna Therapeutics - Peter de Haan, CSO
  7. Astraveus - Jérémie Laurent , CTO and Founder

13: 00   LUNCH BREAK


14: 00   One-to-one partnering meetings (20 minutes/meeting)

Connect with the main European players in the field of gene therapy to build future collaborations




Closed since 31 July 2018


Imagine - Institut des Maladies Génétiques
Boulevard du Montparnasse 24
Paris, France

Organised by


Participants 99
Meetings 126


Australia 1
Belgium 8
France 102
Germany 2
Israel 1
Italy 1
Netherlands 14
Spain 2
Switzerland 2
Turks And Caicos Islands 1
United Kingdom 4
United States 4
Total 142


Large Company 20
University 11
R&D Institution 28
Cluster/Association/Agency 9
Authority/Government 5
Consulting 6
Hospital 10
Investor 6
Technology Transfer Organization 8
SME 39
Total 142